Exploration and identification of anoikis-related genes in polycythemia vera

Exploration and identification of anoikis-related genes in polycythemia vera

Background: Polycythemia Vera (PV) is a type of typical Myeloproliferative Neoplasms (MPNs) characterized with excessive erythropoiesis and thrombosis. Anoikis is a special programmed cell death mode induced by the adhesion disorder between cells and extracellular matrix (ECM) or adjacent cells faci...

Full description

Bibliographic Details
Main Authors:	Wufuer Aini, Limin Xie, Wanyu Hu, Yuan Tang, Hongling Peng, Guangsen Zhang, Tuo Deng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Genetics
Subjects:	myeloproliferative neoplasms anoikis-related genes differentially expressed genes protein-protein interaction hub genes
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1139351/full

Similar Items

An anoikis-related gene signature for prediction of the prognosis in prostate cancer
by: Xiaodong Zhao, et al.
Published: (2023-08-01)

Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis‐related genes in colorectal cancer
by: Xiang Zhai, et al.
Published: (2024-05-01)

Construction of an original anoikis-related prognostic model closely related to immune infiltration in gastric cancer
by: Zhihong Zhao, et al.
Published: (2023-01-01)

Cellular Anchorage Sensing and Anoikis
by: Wei Du, et al.
Published: (2011-03-01)

Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera
by: Benevolo G, et al.
Published: (2023-11-01)

Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction
by: Taohui Ding, et al.
Published: (2024-05-01)

Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer
by: Wanying Kang, et al.
Published: (2024-06-01)

A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma
by: Yi Zhou, et al.
Published: (2023-01-01)

How we treat polycythemia vera
by: V. A. Shuvaev, et al.
Published: (2024-01-01)

Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings
by: Shusheng Zhu, et al.
Published: (2023-12-01)

Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer
by: Xiaolin Liu, et al.
Published: (2023-08-01)

An anoikis-related gene signature predicts prognosis, drug sensitivity, and immune microenvironment in cholangiocarcinoma
by: Guochao Liu, et al.
Published: (2024-06-01)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
by: Yang Chen, et al.
Published: (2023-04-01)

Comprehensive analysis and experimental verification of the mechanism of anoikis related genes in pancreatic cancer
by: Qian Bao, et al.
Published: (2024-08-01)

Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials
by: Heinz Gisslinger
Published: (2023-12-01)

Osteolytic lesion in polycythemia vera: First report and review of literature
by: Verna Cheung, et al.
Published: (2022-05-01)

Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
by: Yalan Dai, et al.
Published: (2023-08-01)

Landscape of genetic alterations of myeloid neoplasms in 305 Chinese cases
by: GOU Yang, et al.
Published: (2019-11-01)

An unusual presentation of blast phase in JAK 2 mutated polycythemia vera
by: Latha Abraham, et al.
Published: (2021-03-01)

The role of erythropoietin levels and other hematological factors in the diagnosis of polycythemia vera in Iraqi patients
by: Aseel Modhfer Al Dayyeni, et al.
Published: (2023-01-01)

FREQUENCY OF MPL AND JAK2 EXON12 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-06-01)

A negative feedback loop between TET2 and leptin in adipocyte regulates body weight
by: Qin Zeng, et al.
Published: (2024-04-01)

FREQUENCY OF CALR GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-04-01)

No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study
by: Ivan Krečak, et al.
Published: (2024-06-01)

The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas
by: Hui Zheng, et al.
Published: (2023-09-01)

Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera
by: Elina A. M. Hirvonen, et al.
Published: (2017-04-01)

Parathyroid Adenoma as a Rare Cause of Persistent Hypercalcemia in a Female with Polycythemia Vera
by: Ahmed M. Abdalhadi, et al.
Published: (2020-05-01)

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
by: Funmilayo O. Adeshakin, et al.
Published: (2021-03-01)

The influence of COVID-19 on colorectal cancer was investigated using bioinformatics and systems biology techniques
by: Yujia Song, et al.
Published: (2023-06-01)

Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis
by: Mingzheng Tang, et al.
Published: (2024-09-01)

A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer
by: Yiqi Duan, et al.
Published: (2023-06-01)

Masked polycythemia vera in a patient 5 years after gastric bypass surgery: A diagnostic pitfall
by: Daniel Rivera, et al.
Published: (2025-02-01)

Ruxolitinib: a targeted treatment option for patients with polycythemia vera
by: Vaddi K, et al.
Published: (2016-05-01)

A prognostic model for anoikis-related genes in pancreatic cancer
by: Wenbin Song, et al.
Published: (2024-07-01)

An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
by: Tian-Ao Xie, et al.
Published: (2021-12-01)

Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
by: Kittitat Chiaranairungrot, et al.
Published: (2022-12-01)

Identification of key genes and immune infiltration in osteoarthritis through analysis of zinc metabolism-related genes
by: Xiaoxuan You, et al.
Published: (2024-03-01)

Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey
by: Hisashi Ishida, et al.
Published: (2020-07-01)

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
by: Fulvia Pimpinelli, et al.
Published: (2021-07-01)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
by: Stine Ulrik Mikkelsen, et al.
Published: (2018-08-01)